Zomedica Corp. (ZOMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.0540
-0.0020 (-3.57%)
May 9, 2025, 4:00 PM EDT
Zomedica Revenue
In the year 2024, Zomedica had annual revenue of $27.29M with 8.33% growth. Zomedica had revenue of $7.90M in the quarter ending December 31, 2024, with 7.61% growth.
Revenue
27.29M
Revenue Growth
+8.33%
P/S Ratio
1.92
Revenue / Employee
179.51K
Employees
152
Market Cap
52.43M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Zomedica News
- 2 days ago - Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET - Accesswire
- 2 months ago - Zomedica Corp. (ZOMDF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth - Accesswire
- 2 months ago - Zomedica Corp. Announces Transition to OTCQB Venture Market - Accesswire
- 2 months ago - NYSE American to Commence Delisting Proceedings Against Zomedica Corp. (ZOM) - Business Wire
- 2 months ago - Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET - Accesswire
- 3 months ago - Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters - Accesswire
- 3 months ago - Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis - Accesswire